Katsunori Yanagihara

InstitutionNagasaki University Graduate School of Biomedical Sciences
AddressNagasaki
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 6 Covid-19 publications, with a maximum of 2 publications in March 2021
    All Publications
    Bar chart showing 348 publications over 19 distinct years, with a maximum of 33 publications in 2012
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Maeda H, Sando E, Toizumi M, Arima Y, Shimada T, Tanaka T, Tashiro M, Fujita A, Yanagihara K, Takayama H, Yasuda I, Kawachi N, Kohayagawa Y, Hasegawa M, Motomura K, Fujita R, Nakata K, Yasuda J, Morita K, Kohno S, Izumikawa K, Suzuki M, Morimoto K. Epidemiology of Coronavirus Disease Outbreak among Crewmembers on Cruise Ship, Nagasaki City, Japan, April 2020. Emerg Infect Dis. 2021 09; 27(9):2251-2260. PMID: 34423761.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Irifune S, Ashizawa N, Takazono T, Mutantu P, Nabeshima T, Ngwe Tun MM, Ota K, Hirayama T, Fujita A, Tashiro M, Tanaka T, Yamamoto K, Imamura Y, Miyazaki T, Sawai T, Izumikawa K, Yanagihara K, Morita K, Mukae H. Discrepancy of SARS-CoV-2 PCR results due to the sample collection sites and possible improper sampling. J Infect Chemother. 2021 Oct; 27(10):1525-1528. PMID: 34294531.
      Citations:    Fields:    Translation:Humans
    3. Ota K, Yanagihara K, Sasaki D, Kaku N, Uno N, Sakamoto K, Kosai K, Miyazaki T, Hasegawa H, Fujita A, Tashiro M, Tanaka T, Izumikawa K, Ariyoshi K, Mukae H, Yasuda J, Morita K, Kohno S. Detection of SARS-CoV-2 using qRT-PCR in saliva obtained from asymptomatic or mild COVID-19 patients, comparative analysis with matched nasopharyngeal samples. PLoS One. 2021; 16(6):e0252964. PMID: 34111203.
      Citations: 1     Fields:    Translation:Humans
    4. Hosogaya N, Miyazaki T, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Kurokawa T, Kawasaki Y, Hanawa M, Fujii Y, Hanaoka H, Iwami S, Watashi K, Yamagoe S, Miyazaki Y, Wakita T, Izumikawa K, Yanagihara K, Mukae H, Kohno S. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial. Trials. 2021 Apr 28; 22(1):309. PMID: 33910617.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    5. Kaku N, Ota K, Sasaki D, Akamatsu N, Uno N, Sakamoto K, Kosai K, Hasegawa H, Izumikawa K, Mukae H, Yanagihara K. Had COVID-19 spread in the community before the first confirmed case in Nagasaki, Japan? Microbes Infect. 2021 May-Jun; 23(4-5):104812. PMID: 33781868.
      Citations:    Fields:    Translation:Humans
    6. Ashizawa N, Takazono T, Ohyama K, Nagasaki Y, Okamoto M, Hirayama T, Takahashi K, Yamanashi H, Tashiro M, Hosogaya N, Tanaka T, Yamamoto K, Fukuda Y, Imamura Y, Kawanami T, Miyazaki T, Sawai T, Fukushima K, Yatera K, Yanagihara K, Izumikawa K, Mukae H. Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests. J Infect Chemother. 2021 Jul; 27(7):1033-1038. PMID: 33781691.
      Citations:    Fields:    Translation:HumansPHPublic Health